Clinical Trials Browser

Phase 4 × Dermatologic × 90 days × Clear all

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT03610022 2026-05-19

OPTIVISMO-1

Phase 4 Completed

27 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07587749 2026-05-14

Skin Subs vs Secondary Intention

Phase 4 Not yet recruiting

50 enrolled

Dermatologic

Skin Substitutes

NCT07575230 2026-05-11

Suzetrigine vs Norco-postoperative Mohs Pain

Phase 4 Enrolling by invitation

75 enrolled

Dermatologic

Skin Neoplasms

NCT07574047 2026-05-07

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

Phase 4 Not yet recruiting

108 enrolled

Dermatologic

Melanoma

NCT07092410 2026-04-21

SuRage-EB

Phase 4 Withdrawn

Dermatologic

Melanoma

NCT07504796 2026-04-21

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Recruiting

90 enrolled

Dermatologic

Melanoma

NCT03340506 2026-04-20

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

100 enrolled

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Phase 4 Not yet recruiting

30 enrolled

Dermatologic

Melanoma, Skin Neoplasms